Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

kyowa kirin international uk newco ltd - fentanyl citrate - sublingual tablet - 300microgram

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

kyowa kirin international uk newco ltd - fentanyl citrate - sublingual tablet - 200microgram

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - buprenorphine hydrochloride - sublingual tablet - 8mg

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - buprenorphine hydrochloride - sublingual tablet - 8mg

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - buprenorphine hydrochloride - sublingual tablet - 8mg

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

necessity supplies ltd - buprenorphine hydrochloride - sublingual tablet - 8mg

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

morningside healthcare ltd - buprenorphine hydrochloride - sublingual tablet - 400microgram

Australia - englanti - Department of Health (Therapeutic Goods Administration)

ix biopharma pty ltd - sildenafil citrate, quantity: 70.24 mg (equivalent: sildenafil, qty 50 mg) - capsule - excipient ingredients: magnesium stearate; croscarmellose sodium; sunset yellow fcf; lactose monohydrate; tartrazine; titanium dioxide; gelatin; silicon dioxide; sodium lauryl sulfate - sildenafil is indicated for the treatment of erectile dysfunction in adult males. ,sildenafil is not indicated for use by women.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

ix biopharma pty ltd - sildenafil citrate, quantity: 35.12 mg (equivalent: sildenafil, qty 25 mg) - capsule - excipient ingredients: magnesium stearate; lactose monohydrate; croscarmellose sodium; titanium dioxide; gelatin; silicon dioxide; sodium lauryl sulfate - sildenafil is indicated for the treatment of erectile dysfunction in adult males. ,sildenafil is not indicated for use by women.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - itraconazole, quantity: 100 mg - capsule - excipient ingredients: hypromellose; macrogol 20000; sucrose; hydrolysed maize starch; titanium dioxide; purified water; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - itranox is indicated for use in adults for the treatment of: ? superficial dermatomycoses not responding to topical treatment. ? fungal keratitis which has failed to respond to topical treatment or where the disease is either progressing rapidly or is immediately sight threatening. ? pityriasis versicolor not responding to any other treatment. ? vulvovaginal candidiasis not responding to topical treatment. ? oral candidiasis in immunocompromised patients. ? onychomycosis caused by dermatophytes. ? systemic mycoses: - systemic aspergillosis, histoplasmosis, sporotrichosis. - treatment and maintenance therapy in aids patients with disseminated or chronic pulmonary histoplasmosis infection. - treatment of oropharyngeal and/or oesophageal candidiasis when first line systemic antifungal therapy is inappropriate or has proven ineffective. - treatment of non-invasive candidiasis in non-neutropenic patients when first-line systemic antifungal therapy is inappropriate or has proven ineffective. this may be due to underlying pathology, insensitivity of the pathogen or drug toxicity.